Edwin Jonathan Tucker - Jun 12, 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Chief Medical Officer
Signature
By: /s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Jun 12, 2023
Transactions value $
$0
Form type
4
Date filed
6/13/2023, 08:45 PM
Previous filing
Nov 15, 2021
Next filing
Feb 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +400K $0.00 400K Jun 12, 2023 Voting Common Stock 400K $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on June 12, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.